Related Experiment Video
Updated: May 24, 2026
Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathy
Andrea L Butler1, Adrian T Fung, Andrew B Merkur
1Department of Ophthalmology & Visual Sciences, University of British Columbia, Vancouver, BC.
Objective:
To describe the safety and efficacy of very minimal fluence photodynamic therapy (PDT) for chronic central serous chorioretinopathy (CSC).
Design:
Retrospective case series.
Participants:
Five patients with chronic CSC. Two had previously failed alternative therapies, and one was taking concomitant corticosteroids.
Methods:
Patients were treated with very minimal fluence PDT (12 J/cm(2), 150 mW/cm(2), for 80 seconds). Median follow-up time after PDT was 100 days (range, 51 to 154).
Results:
All patients experienced an improvement in visual acuity and symptoms, as well as complete resolution of subretinal fluid.
Conclusions:
Very minimal fluence PDT appears to be a safe and effective treatment for chronic CSC. Based on these preliminary findings, a randomized controlled trial is warranted.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...